We are looking forward to the start of bellwether trials for the C.R. Bard transvaginal mesh lawsuits. We regularly hear from women who suffered significant harm, allegedly due to pelvic mesh devices manufactured by C.R. Bard and other manufacturers.
New York, New York (PRWEB) May 04, 2013
Transvaginal mesh lawsuits involving products manufactured by C.R. Bard, Inc. continue to move forward in New Jersey’s Atlantic County Supreme Court, Bernstein Liebhard LLP reports. According to an Order issued on April 25th, the first of the litigation’s bellwether trials will begin on September 23, 2013, and will involve a vaginal mesh device used to treat pelvic organ prolapse. Among other things, the Order also sets forth deadlines for the commencement and completion of depositions for the vaginal mesh lawsuits chosen for the bellwether trials. (In re: Pelvic Mesh Litigation/Bard, No. L-6339-10)
“We are looking forward to the start of bellwether trials for the C.R. Bard transvaginal mesh lawsuits. We regularly hear from women who suffered significant harm, allegedly due to pelvic mesh devices manufactured by C.R. Bard and other manufacturers,” says Bernstein Liebhard LLP, a nationwide law firm representing victims of defective drugs and medical devices. Firm partner, Jeffrey S. Grand, is serving as Co- Liaison Counsel in the New Jersey C.R. Bard litigation.
Alleged Transvaginal Mesh Side Effects
Court records indicate that C.R. Bard and other medical device manufacturers have been named in thousands of transvaginal mesh lawsuits filed on behalf of women who suffered serious injuries, including mesh erosion through vaginal tissue, infection, pain, and urinary problems, allegedly due to mesh products used to treat pelvic organ prolapse and stress urinary incontinence. In addition to the C.R. Bard litigation underway in New Jersey, a second litigation has been established in Atlantic County Superior Court for more than 2,660 transvaginal mesh lawsuits involving Ethicon Inc.’s Gynecare pelvic mesh devices. (In re: Pelvic Mesh/Gynecare Litigation, No. 6341-10). In March, the nation’s first trial involving a Gynecare product concluded in the New Jersey litigation, with the jury awarding more than $11 million to the Plaintiff, including $7.76 million in punitive damages. Bernstein Liebhard LLP partner, Jeffrey S. Grand, is also serving as Co-Liaison Counsel in that litigation, and served on the trial team for the Ethicon mesh lawsuit.
In addition to the vaginal mesh lawsuits pending in the New Jersey litigations, additional claims have been filed in consolidated proceedings now underway in U.S. District Court, Southern District of West Virginia, including: American Medical Systems, Inc., Pelvic Repair Systems Products Liability Litigation (“MDL No. 2325”); In re: Boston Scientific Corp., Pelvic Repair Systems Products Liability Litigation (“MDL No. 2326); In re: C.R. Bard, Inc., Pelvic Repair Systems Products Liability Litigation (“MDL No. 2187”); and In re: Ethicon, Inc., Pelvic Repair Systems Products Liability Litigation (“MDL No. 2327”). Mr. Grand is also serving on the Plaintiffs’ Steering Committee in these four proceedings.
Pelvic mesh products have been the subject of growing litigation since October 2008, when the U.S. Food & Drug Administration (FDA) revealed that it had received more than 1,000 reports of serious transvaginal mesh side effects over a three year period. In July 2011, the FDA warned that there had been a five-fold increase in reports of serious complications associated with the use of pelvic mesh in prolapse repair since its previous alert. The agency also modified the position it had taken in 2008 regarding frequency of such complications, stating in the alert that these injuries were not rare.*
Victims of alleged transvaginal mesh side effects may be entitled to compensation for their medical bills, pain and suffering, and other injuries. A wealth of information regarding vaginal mesh lawsuits can be found at Bernstein Liebhard's website. To learn more, please call 1-877-779-1414.
About Bernstein Liebhard LLP
Bernstein Liebhard LLP is a New York-based law firm exclusively representing injured persons in complex individual and class action lawsuits nationwide since 1993, including those who have been harmed by dangerous drugs, defective medical devices and consumer products. The firm has been named by The National Law Journal to the “Plaintiffs’ Hot List,” recognizing the top plaintiffs’ firms in the country, for the past 10 consecutive years.
Bernstein Liebhard LLP
10 East 40th Street
New York, New York 10016
ATTORNEY ADVERTISING. © 2013 Bernstein Liebhard LLP. The law firm responsible for this advertisement is Bernstein Liebhard LLP, 10 East 40th Street, New York, New York 10016, (212) 779-1414. Prior results do not guarantee or predict a similar outcome with respect to any future matter.
# # #
Felecia L. Stern, Esq.
Bernstein Liebhard LLP